— Know what they know.
Not Investment Advice

BXP vs ARE vs VNO

161 measures in 16 categories, one definition each, computed from filings and market data.
BXP36.3
BXP, Inc.
Real Estate · REIT - Office
$59.20 −0.80%$9.5B mkt cap
Score DNA
ARE24.0
Alexandria Real Estate Equities, Inc.
Real Estate · REIT - Office
$41.62 −1.75%$7.3B mkt cap
Score DNA
VNO27.1
Vornado Realty Trust
Real Estate · REIT - Office
$32.93 −0.90%$6.1B mkt cap
Score DNA

Price, rebased to 100 three years ago

BXP   ARE   VNO   · weekly adjusted closes
50100150200Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26VNO 164BXP 119ARE 47
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureBXPAREVNO
Insider open-market buys, 180d 0 9 4
Insider $ bought, 180d — $1.70M $0.07M
Congress purchases, 180d 2 2 0
Last Congress purchase 2026-09-11 2026-09-25 —
13F net change in holders +15 +26 +37
ETFs adding shares, 30d 562 558 287
ETFs trimming, 30d 428 451 204
Net ETF funds, 30d +134 +107 +83

Valuation

16 measures
MeasureBXPAREVNO
P/E (TTM) 31.8x
43rd
— 90.6x
71st
PEG (P/E ÷ 3-yr EPS CAGR) — — —
Price / sales 2.7x
38th
2.5x
31st
3.4x
62nd
Price / book 1.8x
85th
0.5x
8th
1.1x
69th
Price / tangible book 2.1x
85th
0.6x
8th
1.3x
69th
Price / free cash flow 26.2x
90th
8.3x
20th
22.7x
80th
Price / operating cash flow 7.4x
46th
5.7x
31st
15.7x
85th
Enterprise value $25.3B
100th
$19.6B
92nd
$14.5B
85th
EV / sales 7.2x
38th
6.6x
23rd
7.9x
69th
EV / EBITDA 13.5x
42nd
46.0x
100th
15.7x
67th
EV / EBIT 27.2x
27th
— 37.0x
73rd
EV / free cash flow 70.0x
90th
22.4x
20th
53.7x
70th
Earnings yield 3.1%
77th
-12.5%
15th
1.1%
62nd
FCF yield 3.8%
31st
12.1%
85th
4.4%
38th
Operating cash flow yield 13.6%
54th
17.6%
69th
6.4%
15th
Graham number (per share) $36.79
86th
— $15.88
43rd

Profitability (TTM)

12 measures
MeasureBXPAREVNO
Gross margin 46.8%
38th
69.5%
92nd
42.6%
31st
EBITDA margin 53.0%
46th
14.4%
8th
50.7%
38th
Operating margin 35.0%
85th
-45.7%
0th
10.9%
15th
EBIT margin 26.4%
69th
-28.6%
8th
21.5%
46th
Net margin 8.4%
69th
-30.6%
8th
3.7%
62nd
NOPAT margin 35.0%
92nd
-36.1%
0th
8.5%
15th
FCF margin 10.3%
31st
29.6%
69th
14.8%
54th
Operating cash flow margin 36.5%
38th
43.3%
62nd
21.4%
15th
R&D / revenue 0.0%
0th
0.0%
0th
0.0%
0th
SG&A / revenue 3.9%
0th
4.4%
15th
8.7%
85th
Stock comp / revenue 1.3%
38th
1.3%
54th
1.4%
62nd
Effective tax rate 0.0%
0th
21.0%
54th
22.0%
100th

Returns on capital

11 measures
MeasureBXPAREVNO
ROE (on average equity) 5.7%
77th
-5.5%
15th
1.1%
62nd
ROA 1.2%
69th
-2.5%
15th
0.4%
62nd
ROIC 5.9%
100th
-3.8%
0th
1.1%
15th
ROCE 3.8%
69th
-2.8%
8th
2.6%
54th
Return on tangible assets 3.7%
77th
-2.3%
8th
2.5%
54th
Cash ROIC (OCF / invested capital) 6.1%
69th
4.6%
31st
2.8%
15th
Gross profitability (GP / assets) 6.5%
77th
5.9%
62nd
5.0%
38th
ROIC, 3-yr average 2.3%
77th
-1.1%
15th
2.2%
69th
ROIC, 5-yr average 2.8%
85th
0.0%
15th
1.4%
54th
ROE, 5-yr average 6.2%
85th
-0.0%
31st
2.7%
62nd
Incremental ROIC -113.8%
31st
43.0%
77th
-55.5%
38th

Growth

17 measures
MeasureBXPAREVNO
Revenue growth (TTM YoY) 1.9%
54th
-2.1%
8th
1.4%
38th
Revenue growth (QoQ) 2.7%
69th
18.6%
100th
0.7%
15th
Revenue CAGR, 3 yr 3.2%
62nd
2.8%
54th
0.1%
46th
Revenue CAGR, 5 yr 4.8%
69th
8.2%
92nd
4.1%
54th
Gross profit CAGR, 3 yr -6.7%
38th
2.7%
77th
-5.9%
46th
Operating income CAGR, 3 yr 5.9%
82nd
— -13.9%
36th
Net income growth (TTM YoY) — — -92.2%
0th
Net income CAGR, 3 yr -23.6%
33rd
— —
EPS growth (TTM YoY) — — -91.7%
0th
EPS CAGR, 3 yr -24.0%
33rd
— —
EPS CAGR, 5 yr -1.6%
67th
— —
FCF growth (TTM YoY) -48.5%
11th
-38.3%
22nd
-80.5%
0th
FCF CAGR, 3 yr -27.2%
30th
-17.3%
40th
-31.1%
10th
Operating cash flow CAGR, 3 yr 0.1%
69th
-6.2%
38th
-19.3%
15th
Book value CAGR, 3 yr -5.6%
54th
-9.1%
23rd
1.6%
100th
Dividend CAGR, 3 yr -8.1%
54th
-11.3%
31st
1.4%
92nd
Sustainable growth rate -4.8%
29th
— -2.3%
57th

Margin history & stability

7 measures
MeasureBXPAREVNO
Gross margin, 3-yr average 52.1%
38th
69.8%
85th
72.4%
92nd
Operating margin, 3-yr average 34.1%
100th
0.4%
0th
13.7%
23rd
Net margin, 3-yr average 4.5%
46th
-8.6%
31st
18.9%
100th
FCF margin, 3-yr average 20.1%
54th
39.2%
69th
41.6%
85th
Revenue stability (0-1) 0.96
85th
0.81
62nd
0.68
54th
Earnings stability (0-1) 0.26
15th
0.81
92nd
0.16
8th
Margin stability (0-1) 0.88
62nd
0.98
92nd
0.63
0th

Liquidity (latest quarter)

7 measures
MeasureBXPAREVNO
Cash & short-term investments $553.5M
92nd
$470.4M
85th
$675.4M
100th
Net cash (− = net debt) −$15.8B
0th
−$12.3B
8th
−$8.4B
15th
Working capital −$42.2M
31st
−$4.1B
0th
$1.3B
100th
Current ratio 0.94
33rd
0.11
0th
4.77
92nd
Quick ratio 0.94
33rd
0.11
0th
4.77
92nd
Cash ratio (cash + ST investments / current liabilities) 0.74
83rd
0.10
25th
1.91
100th
Defensive interval (days) 623 days
54th
51 days
0th
993 days
69th

Leverage & solvency (latest quarter)

13 measures
MeasureBXPAREVNO
Total debt $16.4B
100th
$12.8B
92nd
$9.1B
85th
Debt / equity 3.17
92nd
0.82
0th
1.57
69th
Net debt / equity 3.06
92nd
0.79
0th
1.45
54th
Debt / assets 65.0%
92nd
37.0%
0th
58.0%
69th
Debt / capital 76.0%
92nd
45.2%
0th
61.0%
69th
Debt / EBITDA 8.77
58th
30.10
100th
9.77
75th
Net debt / EBITDA 8.47
58th
29.00
100th
9.04
75th
Interest coverage (EBIT / interest) 1.5x
69th
−3.4x
0th
1.1x
62nd
Cash interest coverage 2.1x
54th
5.1x
100th
1.1x
23rd
Debt payback (years of OCF) 12.7 yrs
62nd
10.0 yrs
46th
23.2 yrs
85th
Liabilities / assets 69.3%
92nd
44.7%
0th
57.1%
31st
IS credit model rating CCC CCC BB-
Implied credit spread (bps) 1,200
77th
1,200
77th
550
23rd

Efficiency

11 measures
MeasureBXPAREVNO
Asset turnover 0.14
77th
0.08
0th
0.12
54th
Fixed asset turnover — 0.10
0th
2.74
88th
Inventory turnover — — —
Receivables turnover 26.6
85th
424.7
100th
2.2
0th
Days sales outstanding 14 days
15th
1 days
0th
166 days
100th
Days inventory outstanding — — —
Days payables outstanding 93 days
23rd
590 days
100th
120 days
54th
Cash conversion cycle (days) −79 days
31st
−589 days
0th
46 days
100th
Capex / revenue 26.3%
85th
13.6%
46th
6.6%
31st
Capex / depreciation 0.99
77th
0.32
38th
0.22
23rd
Operating expense ratio — 70.8%
100th
—

Cash flow & earnings quality

7 measures
MeasureBXPAREVNO
Operating cash flow / net income 4.33
57th
— 5.76
71st
FCF / net income 1.22
29th
— 3.99
86th
FCF / operating cash flow 28.1%
31st
68.5%
62nd
69.2%
69th
Capex / operating cash flow 71.9%
69th
31.5%
38th
30.8%
31st
Accruals ratio -3.9%
62nd
-6.0%
38th
-2.1%
100th
Sloan accruals ratio -6.0%
54th
-9.2%
15th
-3.7%
69th
Earnings quality score (0-1) 1.00
29th
— 1.00
29th

Dividends & buybacks

9 measures
MeasureBXPAREVNO
Dividend yield 4.7%
46th
6.9%
77th
2.2%
15th
Dividend per share (TTM) $2.80
92nd
$2.88
100th
$0.74
23rd
Payout ratio (dividends / net income) 183.7%
67th
— 299.6%
83rd
Dividends / FCF 151.2%
100th
80.1%
70th
75.2%
60th
Dividend growth (YoY) -21.7%
54th
-30.5%
23rd
7.5%
85th
Buyback yield 0.0%
54th
0.0%
8th
2.2%
100th
Shareholder yield (dividends + buybacks) 5.8%
38th
9.7%
85th
5.5%
23rd
Share count change (YoY) 0.6%
54th
10.7%
85th
-6.9%
0th
Buybacks, last 5 years $4.3M
54th
$627.4M
100th
$213.3M
92nd

Scores & forensic checks

15 measures
MeasureBXPAREVNO
IS score 36
69th
24
15th
27
46th
IS profitability 32
46th
23
23rd
10
8th
IS growth 57
77th
31
31st
21
8th
IS value 47
8th
50
31st
62
85th
IS momentum 86
85th
34
0th
56
46th
IS risk (safety) 15
15th
15
15th
15
15th
IS quality 49
46th
45
38th
53
54th
IS balance sheet 21
8th
26
23rd
39
85th
IS earnings quality 88
92nd
70
69th
71
77th
IS cash flow 37
31st
46
38th
47
54th
Piotroski F-score (0-9) 6
54th
4
15th
6
54th
Altman Z-score 0.5
62nd
0.2
38th
0.5
54th
Beneish M-score 5.69
100th
−4.04
15th
−5.45
0th
Ohlson O-score −7.47
8th
−6.94
54th
−7.18
31st
IS credit score 19
15th
15
8th
36
77th

Per share

7 measures
MeasureBXPAREVNO
EPS, diluted (TTM) $1.86
100th
−$4.80
8th
$0.36
62nd
Book value per share $32.34
69th
$82.57
100th
$30.90
62nd
Tangible book per share $48.61
85th
$101.74
100th
$35.19
62nd
Revenue per share $22.03
100th
$15.70
92nd
$9.76
69th
FCF per share $2.26
69th
$4.65
92nd
$1.44
46th
Operating cash flow per share $8.05
100th
$6.79
92nd
$2.09
38th
Cash per share $3.47
92nd
$2.50
77th
$3.61
100th

Size (TTM)

8 measures
MeasureBXPAREVNO
Market cap $9.5B
100th
$7.3B
92nd
$6.1B
85th
Revenue $3.5B
100th
$3.0B
92nd
$1.8B
85th
EBITDA $1.9B
100th
$425.6M
38th
$927.5M
92nd
Net income $296.9M
100th
−$904.0M
0th
$67.9M
69th
Free cash flow $360.8M
85th
$876.1M
100th
$270.6M
77th
Total assets $25.2B
92nd
$34.6B
100th
$15.6B
85th
Shareholders' equity $5.2B
77th
$15.6B
100th
$5.8B
92nd
Employees 826
85th
514
62nd
3,145
100th

Price performance

9 measures
MeasureBXPAREVNO
1 day −0.8% −1.8% −0.9%
1 week +0.3% −8.6% −2.1%
1 month −6.3% −25.1% −5.4%
3 months −12.8% −16.9% −17.1%
6 months +2.0% −14.5% +12.5%
Year to date −12.7% −15.1% −1.6%
1 year −17.4% −45.4% −16.6%
3 years, cumulative +16.0% −54.5% +55.3%
5 years, cumulative −35.4% −74.3% −12.8%

Technicals

4 measures
MeasureBXPAREVNO
RSI 14 39.5 26.8 37.9
From 52-week high −21.0% −47.0% −20.8%
From 52-week low +19.1% +5.6% +34.0%
Beta 1.05 1.18 1.59
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms